Numerous studies have demonstrated that autophagy is involved in epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) acquired resistance in NSCLC, partially due to the inhibition of PI3K/AKT/mTOR signaling pathway [11–14]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.